Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Priority Technology | PRTH | Sep 20, 2024 | 6.75 | +1.35 |
Privia Health Group | PRVA | Sep 20, 2024 | 18.75 | -3.55 |
Pro-Dex | PDEX | Sep 20, 2024 | 26.71 | -3.29 |
ProAssurance | PRA | Sep 20, 2024 | 13.69 | +1.41 |
Procaps Group | PROC | Sep 20, 2024 | 1.68 | -6.67 |
Procept BioRobotics | PRCT | Sep 20, 2024 | 84.99 | +2.66 |
Processa Pharmaceuticals | PCSA | Sep 20, 2024 | 1.36 | -0.73 |
Procore Technologies | PCOR | Sep 20, 2024 | 59.49 | -0.92 |
Procter & Gamble | PG | Sep 20, 2024 | 174.22 | +1.56 |
Professional Diversity Network | IPDN | Sep 20, 2024 | 0.44 | +3.00 |
Proficient Auto Logistics | PAL | Sep 20, 2024 | 16.44 | -4.92 |
Profire Energy | PFIE | Sep 20, 2024 | 1.58 | +3.95 |
Profound Medical | PROF | Sep 20, 2024 | 7.80 | -0.51 |
ProFrac A | ACDC | Sep 20, 2024 | 6.44 | -0.92 |
PROG | PRG | Sep 20, 2024 | 49.49 | +1.37 |
Progress Software | PRGS | Sep 20, 2024 | 57.59 | -0.14 |
Progressive | PGR | Sep 20, 2024 | 259.24 | +1.54 |
Progyny | PGNY | Sep 20, 2024 | 16.62 | +0.97 |
Project Energy Reimagined Acquisition Unit | PEGRU | Sep 20, 2024 | 11.10 | 0.00 |
ProKidney | PROK | Sep 20, 2024 | 2.46 | +2.93 |
Prologis | PLD | Sep 20, 2024 | 125.47 | -2.36 |
ProMIS Neurosciences | PMN | Sep 20, 2024 | 1.23 | 0.00 |
PropertyGuru | PGRU | Sep 20, 2024 | 6.63 | +0.30 |
ProPetro | PUMP | Sep 20, 2024 | 8.24 | +0.12 |
ProPhase Labs | PRPH | Sep 20, 2024 | 2.34 | -6.77 |
ProQR Therapeutics | PRQR | Sep 20, 2024 | 1.73 | -2.81 |
PROS | PRO | Sep 20, 2024 | 18.61 | -3.12 |
ProShares Bitcoin Strategy ETF | BITO | Sep 20, 2024 | 19.04 | -0.68 |
Proshares Ultra FTSE Europe | UPV | Sep 20, 2024 | 67.07 | -3.01 |
ProShares UltraShort Bloomberg Natural Gas | KOLD | Sep 20, 2024 | 63.55 | -10.23 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.